Community pharmacist workflow: Space for Pharmacy-based Interventions and Consultation TimE study protocol.


Journal

The International journal of pharmacy practice
ISSN: 2042-7174
Titre abrégé: Int J Pharm Pract
Pays: England
ID NLM: 9204243

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 04 11 2019
revised: 24 03 2020
accepted: 26 03 2020
pubmed: 30 4 2020
medline: 6 7 2021
entrez: 30 4 2020
Statut: ppublish

Résumé

Pharmacists' roles are expanding to delivering a wider set of professional services including medication management optimisation, vaccinations and screening services. Robust research determining whether pharmacists have the capacity to offer such services in the Australian community pharmacy setting is lacking. This protocol details a mixed methods study that investigates the variation in pharmacists' daily tasks and the workspace they work in as a measure of their workload capacity for expanding pharmacy services. An observational time and motion study will be conducted in up to twenty community pharmacies in metropolitan and rural regions of Australia. A trained observer will follow a pharmacist and record the type, location and duration of tasks undertaken over the course of their working day. Data will be collected and analysed using the electronic Work Observation Method By Activity Timing (WOMBAT) tool. Pharmacists' work patterns will be described as time for each task, and by proportionating multitasking and interruptions. This information will be combined with workspace data collected using floor plans, photographs and a qualitative assessment of the working environment completed by the observer. Analysis will include heat-mapped floor plans visually highlighting pharmacist movements. Pharmacists may provide solutions to the strained health workforce and system. There is limited quantitative evidence on whether pharmacists have the time or work setting to support such needs. The use of time and motion methodology is novel to Australian community pharmacy research, and the findings will provide a better understanding of pharmacists' capacity and work environment.

Sections du résumé

BACKGROUND BACKGROUND
Pharmacists' roles are expanding to delivering a wider set of professional services including medication management optimisation, vaccinations and screening services. Robust research determining whether pharmacists have the capacity to offer such services in the Australian community pharmacy setting is lacking. This protocol details a mixed methods study that investigates the variation in pharmacists' daily tasks and the workspace they work in as a measure of their workload capacity for expanding pharmacy services.
METHODS METHODS
An observational time and motion study will be conducted in up to twenty community pharmacies in metropolitan and rural regions of Australia. A trained observer will follow a pharmacist and record the type, location and duration of tasks undertaken over the course of their working day. Data will be collected and analysed using the electronic Work Observation Method By Activity Timing (WOMBAT) tool. Pharmacists' work patterns will be described as time for each task, and by proportionating multitasking and interruptions. This information will be combined with workspace data collected using floor plans, photographs and a qualitative assessment of the working environment completed by the observer. Analysis will include heat-mapped floor plans visually highlighting pharmacist movements.
DISCUSSION CONCLUSIONS
Pharmacists may provide solutions to the strained health workforce and system. There is limited quantitative evidence on whether pharmacists have the time or work setting to support such needs. The use of time and motion methodology is novel to Australian community pharmacy research, and the findings will provide a better understanding of pharmacists' capacity and work environment.

Identifiants

pubmed: 32347607
doi: 10.1111/ijpp.12625
doi:

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

441-448

Subventions

Organisme : University of New South Wales Scientia Fellowship
ID : Associate Professor Rohina Joshi
Organisme : National Heart Foundation of Australia
ID : 100484 Associate Professor Rohina Joshi
Organisme : National Health and Medical Research Council
ID : 1084657
Organisme : National Health and Medical Research Council
ID : APP1110230
Organisme : National Health and Medical Research Council
ID : APP1125044
Organisme : Australian Government Research Training Program Scholarship

Informations de copyright

© 2020 Royal Pharmaceutical Society.

Références

Australian Government Department of Health, Pharmacy Guild of Australia. Sixth Community Pharmacy Agreement (6CPA). [Internet]. Commonwealth of Australia, 2015. https://www.guild.org.au/__data/assets/pdf_file/0007/6100/6cpa-final-24-may-201558b59133c06d6d6b9691ff000026bd16.pdf (accessed 16 April 2020).
Weir NM et al. Factors influencing national implementation of innovations within community pharmacy: A systematic review applying the Consolidated Framework for Implementation Research. Implemen Sci 2019; 14: 21.
Hattingh HL, Hallett J, Tait RJ. ‘Making the invisible visible’ through alcohol screening and brief intervention in community pharmacies: An Australian feasibility study. BMC Public Health 2016; 16: 1141.
Zermansky AG et al. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 2001; 323: 1340-1343.
Sorensen L et al. Medication reviews in the community: Results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol 2004; 58: 648-664.
Tsuyuki RT et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: The Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med 2002; 162: 1149-1155.
Carter BL et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med 2009; 169: 1996-2002.
Sadek MM et al. Community pharmacy and the extended community pharmacist practice roles: The UAE experiences. Saudi Pharm J 2016; 24: 563-570.
Babar ZU et al. The future of pharmacy practice research - perspectives of academics and practitioners from Australia, NZ, United Kingdom, Canada and USA. Res Social Adm Pharm 2018; 14: 1163-1171.
Tan ECK et al. Stakeholder experiences with general practice pharmacist services: A qualitative study. BMJ Open 2013; 3: e003214.
Duckett S, Breadon P, Ginnivan L. Access all areas: New solutions for GP shortages in rural Australia. Report No. 2013-11. [Internet]. Grattan Institute, 2013. https://grattan.edu.au/wp-content/uploads/2014/04/196Access-All-Areas.pdf (accessed 16 April 2020).
Buss VH et al. The impact of clinical services provided by community pharmacies on the Australian healthcare system: A review of the literature. J Pharm Policy Pract 2018; 11: 1-10.
Hoti K et al. An evaluation of Australian pharmacist’s attitudes on expanding their prescribing role. Pharm World Sci 2010; 32: 610-621.
Hoti K, Hughes J, Sunderland B. An expanded prescribing role for pharmacists - An Australian perspective. Australasian Med J 2011; 4: 236-242.
Australian Medical Association (AMA). General Practice Pharmacists - Improving patient care. [Internet]. AMA, 2015. https://ama.com.au/system/tdf/documents/Pharmacists_in_General_Practice_Proposal.pdf?file=1&type=node&id=42083 (accessed 16 April 2020).
McMillan SS et al. Australian community pharmacy services: A survey of what people with chronic conditions and their carers use versus what they consider important. BMJ Open 2014; 4: e006587.
Anderson S. The state of the world's pharmacy: A portrait of the pharmacy profession. J Interprofessional Care 2002; 16: 391-404.
Moles RJ, Stehlik P. Pharmacy practice in Australia. Canadian J Hospital Pharm 2015; 68: 418-426.
Gregorio J, Cavaco AM, Lapao LV. How to best manage time interaction with patients? Community pharmacist workload and service provision analysis. Res Social Adm Pharm 2017; 13: 133-147.
Roberts AS et al. Implementing cognitive services in community pharmacy: A review of facilitators used in practice change. Int J Pharm Pract 2006; 14: 163-170.
Minard LV et al. Pharmacists' perceptions of the barriers and facilitators to the implementation of clinical pharmacy key performance indicators. PLoS ONE 2016; 11: e0152903.
Roberts AS et al. Practice change in community pharmacy: Quantification of facilitators. Ann Pharmacother 2008; 42: 861-868.
Bradley F, Ashcroft DM, Noyce PR. Integration and differentiation: a conceptual model of general practitioner and community pharmacist collaboration. Res Soc Admin Pharm 2012; 8: 36-46.
Tan ECK et al. Integration of pharmacists into general practice clinics in Australia: The views of general practitioners and pharmacists. Int J Pharm Pract 2014; 22: 28-37.
Shoemaker SJ et al. Application of the Consolidated Framework for Implementation Research to community pharmacy: A framework for implementation research on pharmacy services. Res Social Adm Pharm 2017; 13: 905-913.
Hattingh HL. The regulation of pharmacy ownership in Australia: The potential impact of changes to the health landscape. J Law Med 2011; 19: 147-154.
Rapport F, Doel MA, Jerzembek GS. “Convenient space” or “a tight squeeze”: Insider views on the community pharmacy. Health Place 2009; 15: 315-322.
Emmett D et al. Pharmacy layout: What are consumers’ perceptions? J Hospital Market Public Relations 2006; 17: 67-77.
Hattingh HL et al. Utilization of community pharmacy space to enhance privacy: A qualitative study. Health Expect 2016; 19: 1098-1110.
Jakupi A, Jakupi A. Architecture impact in improving the quality of services in retail pharmacies: Case study in Prishtina, Kosovo. J Econ Soc Develop 2017; 4: 51-62.
Fisher AM et al. Measuring time utilization of pharmacists in the Birmingham Free Clinic dispensary. BMC Health Serv Res 2016; 16: 529.
Bratt JH et al. A comparison of four approaches for measuring clinician time use. Health Policy Plan 1999; 14: 374-381.
Lopetegui M et al. Time motion studies in healthcare: what are we talking about? J Biomed Inform 2014; 49: 292-299.
Zheng K, Guo MH, Hanauer DA. Using the time and motion method to study clinical work processes and workflow: Methodological inconsistencies and a call for standardized research. J Am Med Inform Assoc 2011; 18: 704-710.
Finkler SA et al. A comparison of work-sampling and time-and-motion techniques for studies in health services research. Health Serv Res 1993; 28: 577-597.
Davies JE, Barber N, Taylor D. What do community pharmacists do? Results from a work sampling study in London. Int J Pharm Pract 2014; 22: 309-318.
De Clifford J-M et al. How do clinical pharmacists spend their working day? A time-and-motion study. J Pharm Pract Res 2012; 42: 134-139.
Cavaye D et al. Considering pharmacy workflow in the context of Australian community pharmacy: A pilot time and motion study. Res Social Adm Pharm 2018; 14: 1157-1162.
Mossialos E et al. From "retailers" to health care providers: Transforming the role of community pharmacists in chronic disease management. Health Policy 2015; 119: 628-639.
Australian Institute of Health and Welfare. Australia’s health 2016. Australia’s health series no. 15. Cat. no. AUS 199. [Internet]. AIHW, 2016. https://www.aihw.gov.au/getmedia/9844cefb-7745-4dd8-9ee2-f4d1c3d6a727/19787-AH16.pdf.aspx?inline=true (accessed 16 April 2020).
Health Workforce Australia. Australia’s health workforce series - Pharmacists in focus. [Internet]. 2014. http://iaha.com.au/wp-content/uploads/2014/03/HWA_Australia-Health-Workforce-Series_Pharmacists-in-focus_vF_LR.pdf (accessed 16 April 2020).
Dennis S et al. What evidence is there to support skill mix changes between GPs, pharmacists and practice nurses in the care of elderly people living in the community? Australia New Zealand Health Policy 2009; 6: 23.
McPake B, Mahal A. Addressing the needs of an aging population in the health system: The Australian case. Health Syst Reform 2017; 3: 236-247.
Kim J, de Dear R. Workspace satisfaction: The privacy-communication trade-off in open-plan offices. J Environ Psychol 2013; 36: 18-26.
Rapport F et al. Fit for purpose? OrganisationaL prOdUctivity and woRkforce wellbeIng in workSpaces in Hospital (FLOURISH): a multimethod qualitative study protocol. BMJ Open 2019; 9: e027636.
Martin B, Hanington B. Universal methods of design: 100 ways to research complex problems, develop innovative ideas, and design effective solutions. Beverly, MA: Rockport; 2012.
Sommer R, Sommer B. A practical guide to behavioral research: Tools and techniques. New York: Oxford University Press, 1986.
Greenroyd FL et al. Using evidence-based design to improve pharmacy department efficiency. Health Environ Res Design J 2016; 10: 130-143.
Cudney E et al. Improving flow in healthcare clinics through simulation. In: Proceedings of the 2012 Industrial and Systems Engineering Research Conference: Norcross; 2012: 415-424.
Australian Building Codes Board. The national construction code. In: All relevant sections for Class 6 or Class 9a buildings and AS/NZS 1428.1 2001/2009 and AS/NZS 1428.2 s1992; 2016.
Gordon C et al. Community pharmacist-led clinical services: physician's understanding, perceptions and readiness to collaborate in a Midwestern state in the United States. Int J Pharm Pract 2018; 26: 407-413.
Pharmaceutical Benefits Scheme. Expenditure and prescriptions twelve months to 30 June 2017. 2017.
Walter SR, Ling L, Westbrook J. A guide to the analysis of data from the Work Observation Method by Activity Timing (WOMBAT) system. Macquarie University, 2016.
Westbrook JI, Ampt A. Design, application and testing of the Work Observation Method by Activity Timing (WOMBAT) to measure clinicians' patterns of work and communication. Int J Med Inform 2009: 78 (suppl 1): S25-S33.
Westbrook JI et al. Impact of an electronic medication management system on hospital doctors' and nurses' work: A controlled pre-post, time and motion study. J Am Med Inform Assoc 2013; 20: 1150-1158.
Gwet KL. Handbook of inter-rater reliability: The definitive guide to measuring the extent of agreement among multiple raters, 4th edn. Gaithersburg: Advanced Analytics, LLC, 2014.
Georgiou A et al. Impact of an electronic medication management system on hospital doctors' and nurses' work: A controlled pre-post, time and motion study. J Am Med Inform Assoc 2013; 20: 1150-1158.
Paradis E, Sutkin G. Beyond a good story: from Hawthorne Effect to reactivity in health professions education research. Med Educ 2017; 51: 31-39.
Thompson L, Bidwell S. Space, time, and emotion in the community pharmacy. Health Place 2015; 34: 251-256.
Thomas DR. A general inductive approach for analyzing qualitZ:\BW\journals\W3G\IJPP\12625ative evaluation data. Am J Eval 2006; 27: 237-246.

Auteurs

Ajay Mahendrarai Karia (AM)

School of Public Health, Faculty of Health Sciences, Curtin University, Perth, WA, Australia.

Christine Balane (C)

The George Institute for Global Health, UNSW, Sydney, NSW, Australia.

Richard Norman (R)

School of Public Health, Faculty of Health Sciences, Curtin University, Perth, WA, Australia.

Suzanne Robinson (S)

Health Systems Health Economics, Faculty of Health Sciences, Curtin University, Perth, WA, Australia.

Elin Lehnbom (E)

Department of Pharmacy, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromso, Norway.
Department of Health and Caring Sciences, Faculty of Health and Life Sciences, Linnaeus University, Kalmar, Sweden.

Iva Durakovic (I)

Interior Architecture, Faculty of Built Environment UNSW, Sydney, NSW, Australia.

Tracey-Lea Laba (TL)

Centre for Health Economics Research and Evaluation, The University of Technology Sydney, Sydney, NSW, Australia.
The George Institute for Global Health, UNSW, Sydney, NSW, Australia.

Rohina Joshi (R)

Faculty of Medicine, The George Institute for Global Health, UNSW Sydney, Sydney, NSW, Australia.
The George Institute for Global Health India, New Delhi, India.

Ruth Webster (R)

Technical Transfer, The George Institute for Global Health, UNSW, Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH